Back to results
UnknownPhase 2

A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

NCT00907959

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

M.D. Anderson Cancer Center

Houston, Texas, United States

Contact

Mary Tagliaferri, MD

5106012000mary@bionovo.com
View on ClinicalTrials.gov
A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer — TrialFind